Sydney Head and Neck Cancer Institute, Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Camperdown, NSW, Australia; Sydney Medical School, Faculty of Medicine and Health Sciences, The University of Sydney, NSW, Australia; Royal Prince Alfred Institute of Academic Surgery, Sydney Local Health District, NSW, Australia.
Department of Tissue Pathology and Diagnostic Oncology, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, Sydney, Australia.
Oral Oncol. 2021 Apr;115:105162. doi: 10.1016/j.oraloncology.2020.105162. Epub 2021 Feb 3.
Over the last few decades evidence has accumulated for increasing incidence of oral cavity squamous cell carcinoma (OSCC) in a younger cohort. Prior studies examining the effect of age at diagnosis on prognosis have produced conflicting data.
A multi-institutional cohort study was performed across 6 different sites in Australia, Canada, India and Singapore. Disease-free (DFS), overall (OS) and disease-specific (DSS) survival were analysed. The association of the number of adverse features with survival outcomes was investigated.
From 3179 patients, age was a significant predictor of OS with patients older than 45 years having a 66% increased risk of death (HR 1.66, 95%CI 1.33 - 2.07, p < 0.001). The number of adverse features was a significant predictor of OS with 3 or more adverse features having a 199% increased risk (HR 2.99, 95%CI 2.61-3.43. p < 0.001). The estimate effect was greater in patients ≤ 45 years (HR 3.49 vs HR 2.81). Age was not a significant predictor of DSS with similar rates of death from OSCC in multivariable models. The number of adverse features was a significant predictor of DFS with ≥ 3 adverse features having a 140% increased risk of death. The number of adverse features was a significant predictor of DSS with ≥ 3 adverse features having a 230% increased risk of disease specific death.
Age is not an independent predictor of disease specific mortality in OSCC. Differences in outcomes are due to the confounding effect of adverse clinicopathological features and the ability to tolerate surgery and adjuvant therapy.
在过去几十年中,口腔鳞状细胞癌(OSCC)在年轻患者中的发病率不断增加,这一现象已经得到了越来越多的证据支持。先前的研究表明,诊断时的年龄与预后有关,但这些研究结果存在矛盾。
本研究为多机构队列研究,共纳入来自澳大利亚、加拿大、印度和新加坡 6 个不同地点的 3179 名患者。无病生存(DFS)、总生存(OS)和疾病特异性生存(DSS)是主要分析指标。本研究还分析了不良特征数量与生存结果的关系。
研究结果显示,年龄是 OS 独立的预测因素,年龄大于 45 岁的患者死亡风险增加 66%(HR 1.66,95%CI 1.33-2.07,p<0.001)。3 个或更多不良特征是 OS 的独立预测因素,具有 3 个或更多不良特征的患者死亡风险增加 199%(HR 2.99,95%CI 2.61-3.43,p<0.001)。在年龄≤45 岁的患者中,这一估计效果更大(HR 3.49 与 HR 2.81)。年龄不是 DSS 的独立预测因素,多变量模型中 OSCC 患者的死亡率相似。不良特征数量是 DFS 的独立预测因素,具有≥3 个不良特征的患者死亡风险增加 140%。不良特征数量是 DSS 的独立预测因素,具有≥3 个不良特征的患者疾病特异性死亡风险增加 230%。
年龄不是 OSCC 疾病特异性死亡率的独立预测因素。结果差异归因于不良临床病理特征的混杂影响,以及对手术和辅助治疗的耐受能力。